Geoffrey Gifford

Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.

E. Groman, V. M. Holers, D. Simberg, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles

Seyed Moein Moghimi, Laura Saba, E. Groman, 2018, Nature Nanotechnology.

Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.

E. Groman, D. Simberg, L. Saba, 2020, Bioconjugate chemistry.

Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies.

D. Simberg, R. Scheinman, V. Vu, 2019, Molecular pharmaceutics.